Medication info
Dapagliflozin Propanediol Monohydrate 10 mg

Dapagliflozin Propanediol Monohydrate 10 mg

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
Yellow, film-coated, diamond-shaped, biconvex tablets
Packaging
PTP - 28 tablets/box [7 tablets/PTP x 4], Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202202457 · Approved 2022.06.13 · Insurance code 645306800

Summary

Main use
Treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this medication is used with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medication when used in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medication is 10 mg once daily. Special populations Renal impairment - eGFR <45 mL/min/1.73m2: Use of this medication to improve glycemic control is not recommended. - eGFR <25 mL/min/1.73m2: Initiation of this medication is not recommended in patients with chronic heart failure or chronic kidney disease. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years: The efficacy and safety of dapagliflozin in children under 18 years have not been established. No relevant data are available.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease

  • Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular diseases
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • reduced glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medication helps manage blood sugar levels in patients with type 2 diabetes, complementing dietary and exercise regimens. It can be used alone or in combination with other treatments. Additionally, it aids in reducing the risk of death and hospitalization due to cardiovascular diseases in patients with chronic heart failure, and it is administered alongside other heart failure treatments. It is also used in patients with chronic kidney disease to mitigate the decline in kidney function and associated mortality risk. In this way, it is used to prevent complications related to diabetes, heart failure, and kidney disease and to improve health.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this medication is used with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medication when used in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medication is 10 mg once daily. Special populations Renal impairment - eGFR <45 mL/min/1.73m2: Use of this medication to improve glycemic control is not recommended. - eGFR <25 mL/min/1.73m2: Initiation of this medication is not recommended in patients with chronic heart failure or chronic kidney disease. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years: The efficacy and safety of dapagliflozin in children under 18 years have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who are allergic to its active ingredient or excipients, or in those with type 1 diabetes or diabetic ketoacidosis. Additionally, it should not be taken by patients with lactose intolerance, specific genetic disorders, or those undergoing dialysis. Use with caution in patients with dehydration or poor kidney function, and blood pressure and kidney function should be closely monitored before and after administration. In patients with moderate to severe reduction in kidney function, the blood sugar control effect may be diminished, so attempting to manage blood sugar with this medication alone is not recommended. During treatment, genital infections and urinary tract infections may occur; immediate treatment is required if symptoms appear. Hypoglycemic symptoms may occur; hence, careful monitoring of blood sugar is necessary, especially when taken with medications such as insulin or sulfonylureas. Symptoms of dehydration or hypotension could present due to decreased fluid volume, and medical consultation is advised if these symptoms occur. There is a risk of developing severe metabolic dysfunction known as diabetic ketoacidosis; if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, immediate medical attention is advised. Caution is required for elderly patients and those on diuretics due to a higher risk of fluid volume depletion. Pregnant or breastfeeding women should avoid using this medication, and if pregnancy is confirmed, it should be discontinued immediately. There is no specific antidote in case of overdose, and treatment should be administered based on symptoms, following medical guidance. This medication does not significantly impact driving or machine operation, but caution is advised in case of hypoglycemia. Finally, this medication should be stored out of reach of children and kept in its original container for safety.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, necrotizing fasciitis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased early treatment renal creatinine clearance, dyslipidemia, increased blood creatinine at the onset of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric cancer, anaphylactic reaction, chest pain, chronic gastritis, intestinal diverticula, intra-abdominal air retention, frequent bowel movements, gastroenteritis, colonic polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urine, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, rhinitis, toenail fungus, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, fatigue, chest discomfort, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, itching, urticaria, cold sweat, joint pain, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container, protected from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, film-coated, diamond-shaped, biconvex tablets

Package unit

PTP - 28 tablets/box [7 tablets/PTP x 4], Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.